CCCC
Price
$6.72
Change
-$0.19 (-2.75%)
Updated
Apr 19, 6:59 PM EST
13 days until earnings call
FULC
Price
$6.84
Change
-$0.22 (-3.12%)
Updated
Apr 19, 6:59 PM EST
25 days until earnings call
Ad is loading...

Compare trend and price CCCC vs FULC

Header iconCCCC vs FULC Comparison
Open Charts CCCC vs FULCBanner chart's image
C4 Therapeutics
Price$6.72
Change-$0.19 (-2.75%)
Volume$1.18M
CapitalizationN/A
Fulcrum Therapeutics
Price$6.84
Change-$0.22 (-3.12%)
Volume$294.36K
CapitalizationN/A
View a ticker or compare two or three
CCCC vs FULC Comparison Chart

Loading...

CCCCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FULCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CCCC vs. FULC commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and FULC is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (CCCC: $6.91 vs. FULC: $7.06)
Brand notoriety: CCCC and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 44% vs. FULC: 79%
Market capitalization -- CCCC: $473.34M vs. FULC: $437.88M
CCCC [@Biotechnology] is valued at $473.34M. FULC’s [@Biotechnology] market capitalization is $437.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than FULC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while FULC’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 5 bearish.
  • FULC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than FULC.

Price Growth

CCCC (@Biotechnology) experienced а -11.30% price change this week, while FULC (@Biotechnology) price change was -9.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 07, 2024.

FULC is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CCCC with price predictions.
OPEN
A.I.dvisor published
a Summary for FULC with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CCCC($473M) has a higher market cap than FULC($438M). CCCC YTD gains are higher at: 22.301 vs. FULC (4.593).
CCCCFULCCCCC / FULC
Capitalization473M438M108%
EBITDAN/AN/A-
Gain YTD22.3014.593486%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CCCCFULC
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CCCCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FULCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAYLX70.610.25
+0.36%
Oakmark Select Advisor
RYDKX84.590.06
+0.07%
Rydex Dow Jones Industrial Average® C
JSCBX16.420.01
+0.06%
JHancock Small Cap Value I
MECDX14.22-0.09
-0.63%
MainStay Epoch Capital Growth A
NWHZX72.88-0.47
-0.64%
Nationwide Geneva Small Cap Gr A